In a patient taking hydrochlorothiazide, what is the significance and recommended work‑up for an elevated red blood cell count, elevated hematocrit, low mean corpuscular hemoglobin concentration, and elevated red cell distribution width?

Evaluation of Elevated RBC, Elevated Hematocrit, Low MCHC, and Elevated RDW in a Patient Taking Hydrochlorothiazide

This laboratory pattern most likely represents iron deficiency anemia with hemoconcentration from diuretic therapy, and you should immediately order a complete iron panel (serum ferritin, transferrin saturation, serum iron, TIBC) along with C-reactive protein to confirm iron deficiency while the patient continues hydrochlorothiazide. 1, 2, 3

Understanding the Laboratory Pattern

Hemoconcentration from Hydrochlorothiazide

• Hydrochlorothiazide causes natriuresis and volume contraction, which concentrates the cellular components of blood, artificially elevating both RBC count and hematocrit even when underlying anemia is present 4
• The FDA label confirms that hydrochlorothiazide "increases the quantity of sodium traversing the distal tubule and the volume of water excreted," leading to plasma volume reduction 4
• This hemoconcentration effect can mask underlying anemia by elevating hematocrit into the normal or high-normal range despite true iron deficiency 4

Iron Deficiency Indicators

• Low MCHC (mean corpuscular hemoglobin concentration) is a specific marker of hypochromia, indicating red blood cells contain less hemoglobin per unit volume than normal, which strongly suggests iron deficiency 1, 2, 3
• Mean corpuscular hemoglobin (MCH) is actually a more reliable marker than MCHC for detecting iron deficiency because it is less dependent on storage conditions and laboratory equipment, and it decreases in both absolute and functional iron deficiency 3
• Elevated RDW (red cell distribution width) indicates increased variation in red cell size (anisocytosis), which is highly suggestive of iron deficiency and distinguishes it from thalassemia trait 5, 1, 2

Compensatory Erythropoiesis

• In iron deficiency anemia, the bone marrow increases erythropoietic activity, leading to an elevated RBC count despite each cell being smaller and hypochromic; this reflects a compensatory response to reduced oxygen-carrying capacity 3
• This explains why RBC count can be elevated even when hemoglobin is low or low-normal 3

Required Diagnostic Work-Up

First-Line Iron Studies

• Order serum ferritin, transferrin saturation, serum iron, total iron-binding capacity (TIBC), and C-reactive protein immediately 1, 2, 3
• Serum ferritin <30 μg/L confirms depleted iron stores when inflammation is absent and is the single most specific test for iron deficiency 1, 2, 3
• Transferrin saturation <15-16% supports iron deficiency and is less affected by acute inflammation than ferritin, helping to differentiate it from anemia of chronic disease 1, 2
• C-reactive protein (CRP) must be measured concurrently because ferritin rises as an acute-phase reactant; a normal CRP is required to interpret low ferritin accurately 1, 2, 3

Interpreting Ferritin in Context

• In patients without inflammation, ferritin <30 μg/L confirms iron deficiency 1, 2, 3
• In patients with inflammation (elevated CRP), ferritin up to 45-100 μg/L may still indicate iron deficiency because ferritin behaves as an acute-phase reactant and may be falsely elevated 3
• Ferritin >150 μg/L makes absolute iron deficiency unlikely even when inflammation is present 3
• Do not dismiss apparently normal ferritin values in inflammatory states, as this can mask true iron deficiency 3

Additional Helpful Tests

• Complete blood count with MCV to determine if the anemia is microcytic, which further supports iron deficiency 5, 1, 2
• Reticulocyte count to assess bone marrow response; a low or inappropriately normal reticulocyte count suggests impaired red cell production consistent with iron deficiency 5, 1, 2

Investigation for Underlying Cause

Common Etiologies

• In premenopausal women, menstrual blood loss is the most common cause of iron deficiency, but gastrointestinal sources must be considered if menstrual losses seem inadequate to explain the deficiency 1, 2
• Assess for gastrointestinal blood loss by taking a careful history of NSAID use, gastrointestinal symptoms (even mild), and dietary factors 1, 2
• Consider celiac disease screening with tissue transglutaminase (tTG) antibody testing, as malabsorption is a significant cause of iron deficiency with a prevalence of approximately 5% in iron deficiency anemia 1
• Evaluate dietary iron intake adequacy, as girls aged 14-18 years typically consume below the recommended 15 mg/day 1

Red Flags Requiring Further Investigation

• In adult men and postmenopausal women with iron deficiency, gastrointestinal malignancy must be excluded even without overt blood loss 2
• If hemoglobin does not rise despite documented adherence to iron supplementation, screen for celiac disease and evaluate for gastrointestinal blood loss 1

Differential Diagnosis When Iron Studies Are Normal

Thalassemia Trait

• If iron studies are normal despite low MCHC and elevated RDW, obtain hemoglobin electrophoresis—especially in individuals of Mediterranean, African, or Southeast Asian descent—to evaluate for thalassemia trait 3
• Thalassemia trait typically shows RDW ≤14% (versus >14% in iron deficiency), normal or borderline iron studies, and an MCV disproportionately low relative to the degree of anemia 1
• In thalassemia trait, the MCV is typically reduced disproportionately to the degree of anemia 3

Other Considerations

• Additional conditions to consider when iron studies are normal include anemia of chronic disease and sideroblastic anemia 5, 3

Treatment Approach

Oral Iron Supplementation

• Initiate oral iron supplementation with ferrous sulfate 60-120 mg elemental iron daily, taken on an empty stomach between meals to maximize absorption 1
• A rise in hemoglobin of ≥1 g/dL (or hematocrit increase ≥3%) within 4 weeks of therapy confirms iron-deficiency anemia even if baseline iron studies are equivocal 1, 3
• Continue iron supplementation for 3-6 months after hemoglobin normalizes to replenish iron stores 1, 2

Monitoring Response

• Re-measure hemoglobin and hematocrit at 4 weeks; an increase meeting the above thresholds validates the diagnosis and warrants continuation of therapy for an additional 3 months (total 4 months) to replenish iron stores 1
• Check hemoglobin, reticulocytes, and iron studies after 4-8 weeks of therapy 3

Alternative Therapies

• Consider intravenous iron if oral iron is not tolerated due to gastrointestinal side effects, if there is malabsorption, or if rapid repletion is needed 5, 1, 2
• Blood transfusion is not indicated for mild anemia; it should be reserved for symptomatic anemia with cardiovascular instability such as fatigue, hypotension, or tachycardia 1

Dietary Recommendations

• Advise consumption of iron-rich foods (red meat, poultry, fish, fortified cereals, beans, lentils) and vitamin C-rich foods (citrus, tomatoes) to enhance absorption 1

Common Pitfalls to Avoid

• Do not rely on MCV alone, as iron deficiency can present with normal MCV in early stages; MCH and MCHC are more sensitive early markers 1, 3
• Do not assume a normal hematocrit excludes anemia in patients taking diuretics; hemoconcentration from volume depletion can mask underlying anemia 4
• Do not dismiss normal ferritin in inflammatory states; use the higher cutoff of 45-100 μg/L depending on inflammation severity 3
• Do not forget to investigate the cause of iron deficiency, as it often indicates ongoing blood loss requiring evaluation 1, 2, 3
• Do not stop investigating if the patient does not respond to oral iron; this suggests malabsorption (celiac disease) or ongoing blood loss 1

Clinical Significance of Elevated RDW

• Elevated RDW is associated with increased mortality and adverse outcomes in critically ill patients, heart failure, and venous thrombosis, independent of anemia 6, 7, 8, 9
• RDW >16% achieves 90% specificity for hospital admission in emergency department patients 6
• In this patient, elevated RDW likely reflects iron deficiency, but it also serves as a marker of overall physiologic stress and warrants close monitoring 6, 7